The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
PTC Therapeutics Inc. (BH3:F) Annual Income Statement ()
BH3:F Quarterly Financials ()
Frequently Asked Questions About PTC Therapeutics Inc. (BH3:F) Stock
PTC Therapeutics Inc.'s (BH3:F) last reported annual revenue was N/A.
PTC Therapeutics Inc.'s (BH3:F) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
PTC Therapeutics Inc.'s(BH3:F) is not profitable as of its last reported annual financials.
The net profit margin for PTC Therapeutics Inc.'s(BH3:F) from its laster reported year is N/A
The return on equity (ROE) for PTC Therapeutics Inc.'s(BH3:F) from its last reported annual financials is : 0.00%
The return on assets (ROA) for PTC Therapeutics Inc.'s(BH3:F) from its last reported annual financials is : -7.39%
The return on invested capital (ROIC) for PTC Therapeutics Inc.'s(BH3:F) from its last reported annual financials is : 0.00%
The Debt to Equity ratio for PTC Therapeutics Inc.'s(BH3:F) from its last reported annual financials is : 0.00%
The dividend yield for PTC Therapeutics Inc.'s(BH3:F) from its laster reported year is 0.00%
PTC Therapeutics Inc.'s(BH3:F) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BH3:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
